# Insitro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insitro

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.insitro.com/
- Total disclosed funding: $643M
- Latest round: Series C (Mar 15, 2021)
- Investors on record: 17

## About

Based in South San Francisco, US, Insitro, Inc. is a biotechnology company focused on transforming drug discovery and development through advanced machine learning techniques and comprehensive data integration.Insitro, Inc. specializes in utilizing advanced machine learning to drive drug discovery and development. Founded in 2018, the company is headquartered in South San Francisco, California. It has completed a total of 3 deals, with the latest funding round being a Series C in March 2021, during which it raised USD 400 mn led by CPP Investment Board, along with participation from notable investors such as Andreessen Horowitz and BlackRock. The CEO and founder of Insitro is Daphne Koller, who has a history of founding and leading innovative ventures in the biotechnology sector.Insitro focuses on revolutionizing drug discovery and development through its advanced machine learning platform. The company offers a suite of ML-driven tools that integrate in vitro cellular data with human clinical data to redefine disease insights and accelerate the therapeutic development process. By leveraging extensive datasets, Insitro aims to unlock transformative medicines targeting areas such as metabolism, oncology, and neuroscience. The clientele includes pharmaceutical partners and research institutions using its platform to enhance drug discovery efforts across North America, Europe, and parts of Asia.Insitro generates revenue through strategic partnerships with major pharmaceutical companies like Bristol Myers Squibb and Lilly. These collaborations typically involve joint research agreements where Insitro's proprietary ML tools facilitate the discovery of new therapeutics. Revenue transactions comprise milestone payments linked to specific research outcomes and potential royalties on future product sales developed through these collaborations, operating primarily under a B2B model.Insitro, Inc. plans to utilize the USD 400 mn raised in its Series C funding round to expand its platform capabilities and pipeline. The company is focusing on developing new products that enhance its machine learning-driven insights and therapeutic offerings. Additionally, Insitro aims to expand its market presence into new geographic regions, including deeper penetration into European and Asian markets by 2023, enhancing its collaboration with pharmaceutical partners to address emerging drug development challenges.

## Funding rounds

- Series C, Mar 15, 2021, $400M — ARCH Venture Partners, T Rowe Price, Temasek Holdings, CPP Investment Board, Alexandria Venture Investments, Third Rock Ventures, Two Sigma Investments, GV, Andreessen Horowitz, BlackRock, Foresite Capital, Casdin Capital, HOF Capital, SB Investment Advisers
- Series B, Mar 26, 2020, $143M — ARCH Venture Partners, T Rowe Price, CPP Investment Board, Alexandria Venture Investments, Third Rock Ventures, Two Sigma Investments, GV, Andreessen Horowitz, BlackRock, Foresite Capital, Casdin Capital, HOF Capital, Wuxi AppTec Group
- Series A, May 2, 2018, $100M — ARCH Venture Partners, Alexandria Venture Investments, Third Rock Ventures, Two Sigma Investments, GV, Andreessen Horowitz, Foresite Capital, Bezos Expeditions, Mubadala Capital

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B, Series C
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A, Series B, Series C
- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series A, Series B, Series C
- Two Sigma Investments (https://capitalatlas.ai/funds/two-sigma-investments) — Series A, Series B, Series C
- GV (https://capitalatlas.ai/funds/gv) — Series A, Series B, Series C
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series A, Series B, Series C
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series A, Series B, Series C
- Bezos Expeditions — Series A
- Mubadala Capital (https://capitalatlas.ai/funds/mubadala-capital) — Series A
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series B, Series C
- CPP Investment Board — Series B, Series C
- BlackRock (https://capitalatlas.ai/funds/blackrock) — Series B, Series C
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series B, Series C
- HOF Capital (https://capitalatlas.ai/funds/hof-capital) — Series B, Series C
- Wuxi AppTec Group — Series B
- Temasek Holdings — Series C
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series C